Frank Z Stanczyk

Author PubWeight™ 221.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003 2.65
2 Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004 2.45
3 Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008 2.44
4 Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertil Steril 2004 2.33
5 Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002 2.27
6 Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 2008 2.21
7 Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 2006 2.17
8 Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008 2.15
9 Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004 2.14
10 Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol 2010 2.00
11 Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 2007 2.00
12 Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception 2010 1.96
13 Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 2012 1.82
14 Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006 1.76
15 Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study. Contraception 2006 1.68
16 Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 2007 1.66
17 Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol 2012 1.66
18 Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 2008 1.63
19 Insulin resistance and prostate cancer risk. J Natl Cancer Inst 2003 1.61
20 Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2013 1.58
21 Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 2011 1.56
22 Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2006 1.56
23 Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 2007 1.53
24 Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception 2009 1.52
25 Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab 2010 1.46
26 Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause 2014 1.46
27 Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol 2006 1.46
28 Effect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome. Fertil Steril 2012 1.45
29 Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate 2003 1.40
30 Reliability of extraction/chromatography RIAs. Clin Chem 2004 1.40
31 Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2007 1.38
32 Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004 1.35
33 Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception 2008 1.34
34 Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 2008 1.34
35 Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2004 1.30
36 Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 2008 1.29
37 Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci U S A 2012 1.26
38 Hormones and prostate cancer: current perspectives and future directions. Prostate 2002 1.26
39 Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005 1.26
40 Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004 1.24
41 Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol 2010 1.23
42 Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 2009 1.16
43 Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 2009 1.14
44 Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomarkers Prev 2008 1.14
45 Predictors of noncompliance in an oral contraceptive clinical trial. Contraception 2011 1.13
46 Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev 2012 1.12
47 Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis 2005 1.12
48 Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 2002 1.11
49 Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin Cancer Res 2006 1.10
50 Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 2005 1.10
51 Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr 2009 1.10
52 No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2005 1.09
53 Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception 2010 1.08
54 Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res 2010 1.08
55 Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev 2005 1.06
56 Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005 1.06
57 A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev 2011 1.06
58 Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res 2004 1.05
59 A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr 2005 1.05
60 UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004 1.05
61 Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. J Natl Cancer Inst 2009 1.04
62 Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev 2004 1.04
63 Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr Relat Cancer 2010 1.04
64 Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception 2012 1.04
65 Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril 2007 1.02
66 Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011 1.02
67 Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila) 2012 1.02
68 Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res 2009 1.01
69 Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat 2007 1.01
70 Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer 2011 1.01
71 Decreased endopelvic fascia elastin content in uterine prolapse. Acta Obstet Gynecol Scand 2008 0.99
72 Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer 2007 0.99
73 Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control 2011 0.98
74 Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Menopause 2015 0.98
75 Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control 2009 0.98
76 Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 2002 0.98
77 Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer 2011 0.98
78 Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling. Cancer Res 2007 0.97
79 Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril 2011 0.97
80 Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial. J Am Acad Dermatol 2002 0.97
81 Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort. Prostate 2010 0.97
82 Soy intake and other lifestyle determinants of serum estrogen levels among postmenopausal Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev 2002 0.97
83 Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Cancer Epidemiol Biomarkers Prev 2008 0.97
84 Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public Health Nutr 2006 0.97
85 Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States). Cancer Causes Control 2006 0.97
86 Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A 2013 0.97
87 Long-term, low-dose lead exposure alters the gonadotropin-releasing hormone system in the male rat. Environ Health Perspect 2002 0.96
88 Androstenediol complements estrogenic bioactivity during the menopausal transition. Menopause 2012 0.96
89 Adolescent diet and subsequent serum hormones, breast density, and bone mineral density in young women: results of the Dietary Intervention Study in Children follow-up study. Cancer Epidemiol Biomarkers Prev 2010 0.96
90 Menopausal transition stage-specific changes in circulating adrenal androgens. Menopause 2012 0.96
91 Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev 2003 0.96
92 A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev 2002 0.95
93 Serum sex hormones and breast cancer risk factors in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003 0.95
94 The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status. Menopause 2008 0.95
95 Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design. Cancer Epidemiol Biomarkers Prev 2004 0.94
96 Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab 2008 0.93
97 Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding. Epilepsia 2011 0.93
98 Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010 0.93
99 Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States. Cancer Causes Control 2008 0.93
100 Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial. Cancer Epidemiol Biomarkers Prev 2011 0.93
101 Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men. Cancer Epidemiol Biomarkers Prev 2013 0.92
102 Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast Cancer Res Treat 2011 0.92
103 Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins. Contraception 2006 0.91
104 Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. Endocrine 2012 0.91
105 The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. Am J Obstet Gynecol 2004 0.91
106 Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res Treat 2006 0.91
107 Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2005 0.91
108 The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 2011 0.91
109 Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi. J Acquir Immune Defic Syndr 2011 0.90
110 Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States. Breast Cancer Res Treat 2008 0.90
111 DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2010 0.89
112 Expression of lysyl oxidase and transforming growth factor beta2 in women with severe pelvic organ prolapse. J Reprod Med 2005 0.89
113 Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 2007 0.89
114 Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA). BMC Cancer 2014 0.89
115 Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. Breast Cancer Res Treat 2002 0.88
116 CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Int J Cancer 2003 0.88
117 Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci 2007 0.88
118 Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab 2009 0.88
119 The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat 2011 0.88
120 Measurement of sex steroid hormones in breast adipocytes: methods and implications. Cancer Epidemiol Biomarkers Prev 2008 0.88
121 Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause 2010 0.87
122 Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal women. Cancer Prev Res (Phila) 2011 0.87
123 Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2011 0.87
124 Effect of oral versus transdermal steroidal contraceptives on androgenic markers. Am J Obstet Gynecol 2005 0.87
125 Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates. Cancer Epidemiol Biomarkers Prev 2008 0.87
126 Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the Partnership for the Accurate Testing of Hormones. Clin Chem 2012 0.86
127 Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women. J Acquir Immune Defic Syndr 2014 0.86
128 The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis. Reprod Sci 2012 0.86
129 Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study. Nutr Cancer 2005 0.85
130 Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Contraception 2008 0.85
131 Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2007 0.85
132 Association between sex hormones, glucose homeostasis, adipokines, and inflammatory markers and mammographic density among postmenopausal women. Breast Cancer Res Treat 2013 0.85
133 Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat 2011 0.85
134 Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc 2006 0.84
135 A pilot and feasibility study on the effects of naturopathic botanical and dietary interventions on sex steroid hormone metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 2007 0.83
136 Maternal hormone levels and risk of cryptorchism among populations at high and low risk of testicular germ cell tumors. Cancer Epidemiol Biomarkers Prev 2005 0.83
137 Bile acid concentration reference ranges in a pregnant Latina population. Am J Perinatol 2012 0.83
138 Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging 2012 0.83
139 Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients. Springerplus 2013 0.83
140 Effects of 60-Hz magnetic field exposure on nocturnal 6-sulfatoxymelatonin, estrogens, luteinizing hormone, and follicle-stimulating hormone in healthy reproductive-age women: results of a crossover trial. Ann Epidemiol 2006 0.83
141 Age-related changes in serum and brain levels of androgens in male Brown Norway rats. Neuroreport 2009 0.83
142 Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Menopause 2012 0.83
143 Formation of ethinyl estradiol in women during treatment with norethindrone acetate. J Clin Endocrinol Metab 2007 0.83
144 Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives. Contraception 2012 0.83
145 Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev 2012 0.82
146 The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health 2002 0.82
147 Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut 2011 0.82
148 Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. Am J Obstet Gynecol 2007 0.82
149 Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutr Cancer 2011 0.82
150 Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. J Clin Endocrinol Metab 2011 0.82
151 Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States. J Steroid Biochem Mol Biol 2010 0.82
152 AKR1C1 and SRD5A1 messenger RNA expression at term in the human myometrium and chorioamniotic membranes. Am J Perinatol 2008 0.81
153 Insulin-like growth factor 1, insulin-like growth factor-binding protein 3, and testicular germ-cell tumor risk. Am J Epidemiol 2008 0.81
154 Percutaneous progesterone delivery via cream or gel application in postmenopausal women: a randomized cross-over study of progesterone levels in serum, whole blood, saliva, and capillary blood. Menopause 2013 0.81
155 The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. J Clin Endocrinol Metab 2010 0.81
156 Effects of alcohol and cigarette smoking on change in serum estrone levels in postmenopausal women randomly assigned to fixed doses of conjugated equine estrogens with or without a progestin. Menopause 2008 0.81
157 Steroid profiling and analytics: going towards sterome. J Steroid Biochem Mol Biol 2010 0.81
158 Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging 2010 0.81
159 Reproducibility studies and interlaboratory concordance for androgen assays of male plasma hormone levels. Cancer Epidemiol Biomarkers Prev 2002 0.81
160 Associations between reproductive and menstrual factors and postmenopausal androgen concentrations. J Womens Health (Larchmt) 2005 0.81
161 An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors. Breast Cancer Res Treat 2006 0.80
162 Maternal hormone levels and perinatal characteristics: implications for testicular cancer. Ann Epidemiol 2006 0.80
163 The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women. Nutr Cancer 2013 0.80
164 Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 2012 0.80
165 Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. Am J Obstet Gynecol 2013 0.80
166 Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 2004 0.79
167 Editorial: The new instructions to authors for the reporting of steroid hormone measurements. J Clin Endocrinol Metab 2014 0.79
168 Treatment-associated serum FSH levels in very poor responders to ovarian stimulation. J Assist Reprod Genet 2003 0.79
169 Longitudinal changes in IGF-I and IGFBP-3, and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2013 0.79
170 Effects of luteinizing hormone receptor signaling in prostate cancer cells. Prostate 2014 0.79
171 Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys. J Clin Endocrinol Metab 2005 0.79
172 Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2002 0.79
173 Comparison of vaginal and oral administration of emergency contraception. Fertil Steril 2005 0.79
174 Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. J Clin Endocrinol Metab 2014 0.79
175 Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use. Contraception 2011 0.79
176 Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev 2008 0.79
177 Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States. Metabolism 2012 0.79
178 Executive functions in recently postmenopausal women: absence of strong association with serum gonadal steroids. Brain Res 2010 0.79
179 Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration. Contraception 2005 0.79
180 Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system. Expert Opin Pharmacother 2015 0.78
181 Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone. Arterioscler Thromb Vasc Biol 2004 0.78
182 Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. Am J Physiol Heart Circ Physiol 2005 0.78
183 Suppression of lysyl oxidase gene expression by methylation in pelvic organ prolapse. Int Urogynecol J 2010 0.78
184 Psychological reactivity to laboratory stress is associated with hormonal responses in postmenopausal women. J Int Med Res 2014 0.78
185 3alpha-Hydroxysteroid dehydrogenase type III deficiency: a novel mechanism for hirsutism. J Clin Endocrinol Metab 2008 0.78
186 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. Am J Geriatr Psychiatry 2003 0.78
187 Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women. Nutr Cancer 2008 0.78
188 Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort. Cancer Epidemiol Biomarkers Prev 2014 0.78
189 Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function. Fertil Steril 2009 0.78
190 Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men. Fertil Steril 2004 0.78
191 Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise. Contraception 2012 0.77
192 Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis 2003 0.77
193 Pharmacologic deficiency in the Women's Health Initiative Study. J Reprod Med 2003 0.77
194 Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Contraception 2012 0.77
195 Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE). Menopause 2016 0.77
196 Does St. John's wort interfere with the antiandrogenic effect of oral contraceptive pills? Contraception 2006 0.77
197 Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Endocrinology 2014 0.77
198 Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel. Contraception 2012 0.77
199 Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial. Contraception 2011 0.76
200 Modulation of higher-primate adrenal androgen secretion with estrogen-alone or estrogen-plus-progesterone intervention. Menopause 2013 0.76
201 A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations. Cancer Epidemiol 2011 0.76
202 Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies. Cancer Causes Control 2012 0.76
203 The role of progestogens in regulating matrix metalloproteinase activity in macrophages and microglial cells. Neurochem Res 2011 0.76
204 Effects of progestin-only long-acting contraception on metabolic markers in obese women. Contraception 2013 0.76
205 Extraction/chromatographic testosterone RIA can be used as the "gold standard" for determining the reliability of direct testosterone immunoassay measurements. Clin Chem 2004 0.76
206 Physical activity and sex hormone levels in estradiol- and placebo-treated postmenopausal women. Menopause 2011 0.76
207 Mediators and moderators of the effects of a year-long exercise intervention on endogenous sex hormones in postmenopausal women. Cancer Causes Control 2011 0.76
208 Measurement of serum estradiol levels in postmenopausal women. JAMA 2002 0.75
209 Parenteral versus oral treatment of postmenopausal women with estrogen. Menopause 2007 0.75
210 Influence of diet on nipple aspirate fluid production and estrogen levels. Food Funct 2011 0.75
211 Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1? Menopause 2011 0.75
212 Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry. Horm Mol Biol Clin Investig 2015 0.75
213 Editorial: The new instructions to authors for the reporting of steroid hormone measurements. Endocr Rev 2014 0.75
214 Effect of hormone therapy on breast epithelial cell proliferation. Menopause 2013 0.75
215 Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus. Cancer Causes Control 2011 0.75
216 Potential contribution of the postmenopausal ovary to the circulating pool of dehydroepiandrosterone. Menopause 2011 0.75
217 Measurement of total testosterone in women: comparison of a direct radioimmunoassay versus radioimmunoassay after organic solvent extraction and celite column partition chromatography. Fertil Steril 2005 0.75
218 Increased insulin-like growth factor-1 after oophorectomy in postmenopausal women. Fertil Steril 2007 0.75
219 Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women. Contraception 2012 0.75
220 Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Mol Endocrinol 2014 0.75
221 Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells. Fertil Steril 2003 0.75
222 A longitudinal study of LH, gonadal and adrenal steroids in four intact Asian bull elephants (Elephas maximus) and one castrate African bull (Loxodonta africana) during musth and non-musth periods. Gen Comp Endocrinol 2007 0.75
223 A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate. Eur J Contracept Reprod Health Care 2013 0.75
224 Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel. Horm Mol Biol Clin Investig 2011 0.75
225 Associations between postmenopausal endogenous sex hormones and C-reactive protein: a clearer picture with regional adiposity adjustment? Menopause 2017 0.75
226 Dry eye in postmenopausal women: a hormonal disorder. Menopause 2016 0.75